To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125
Clinical trial NCT02673567 · COMPLETED
Trial details
- NCT number
- NCT02673567
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-31
- Primary completion
- 2016-12-16
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.